Apellis Pharmaceuticals(us:APLS)

    33.03

    -0.54%

    Updated on 2024-12-23

    Open:33.35
    Close:33.03
    High:33.83
    Low:32.79
    Pre Close:33.21
    Volume:617603.00
    Amount:20.44M
    Turnover:0.50%
    Shares:124.39M
    MarketCap:4.11B

    About

    Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.
    Address:100 5th Avenue

    Market Movers